Risk factors for late cytomegalovirus infection after allogeneic stem cell transplantation using HLA-matched sibling donor: donor lymphocyte infusion and previous history of early CMV infection

This publication has 15 references indexed in Scilit:

• Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation
  Blood, 2003
• Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity
  Blood, 2003
• Large‐volume leukapheresis using femoral venous access for harvesting peripheral blood stem cells with the Fenwal CS 3000 Plus from normal healthy donors: Predictors of CD34+ cell yield and collection efficiency
  Journal of Clinical Apheresis, 2003
• High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution
  Blood, 2002
• Extended antigenemia surveillance and late cytomegalovirus infection after allogeneic BMT
  Bone Marrow Transplantation, 2001
• Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease
  Bone Marrow Transplantation, 1998
• Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease
  Bone Marrow Transplantation, 1997
• Adoptive immunotherapy with donor lymphocyte transfusions
  Current Opinion in Oncology, 1997
• Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
  Blood, 1990
• Chronic graft-versus-host syndrome in man
  The American Journal of Medicine, 1980